Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Arq. bras. med. vet. zootec. (Online) ; 73(1): 191-196, Jan.-Feb. 2021. ilus
Article in English | LILACS, VETINDEX | ID: biblio-1153054

ABSTRACT

Vitiligo is a dermatological disease affecting both animals and humans. It is characterized by depigmented macules of varying shape and size, originated from melanocyte destruction. Even though there are some theories tackling causation, disease etiopathology is not yet certain. Moreover, lesion areas can either increase or diminish over time, and therefore, available treatment alternatives tend to prove inconsistencies. No epidemiological data or registered cases were found for equines in Brazil. The horse in this case description displayed depigmentation areas in facial regions, including upper lip, nose and lips. However, the individual did not happen to develop any systemic alteration. Through clinical evaluation, backed by a histopathological exam, a definitive vitiligo diagnosis was obtained. However, no therapeutic plan was stipulated. The animal was accompanied for four years, during which period some affected areas diminished while others increased in size. In addition, emergence of new skin lesions was also observed during the time the animal was studied. Overall, this disease does not display alterations to organism functionality, only aesthetic changes. Therefore, treatment plans may vary from case to case, occasionally being even ruled out.(AU)


O vitiligo é uma doença dermatológica que pode afetar animais e humanos. Caracteriza-se por áreas despigmentadas, de formas e tamanhos variáveis, que surgem devido a destruição dos melanócitos. Existem algumas teorias que tentam explicar a etiopatogenia da doença, entretanto ainda não é totalmente esclarecida. As lesões podem aumentar ou diminuir com o tempo, por isso os tratamentos disponíveis são inconsistentes. Não foram encontrados dados epidemiológicos ou relatos de vitiligo em cavalos no Brasil. O equino deste relato apresentava lesões despigmentadas na região da face, incluindo pálpebras, narina e lábios, sem alterações sistêmicas. Por meio da avaliação clínica em conjunto com o exame histopatológico obteve-se o diagnóstico definitivo de vitiligo. Não foi instituído nenhuma terapia, e o equino foi acompanhado durante quatro anos. Durante esse período algumas lesões diminuíram e outras aumentaram de tamanho sendo também observado o aparecimento de novas lesões. O vitiligo não traz alterações sistêmicas, apenas mudanças estéticas, por isso a escolha pelo tratamento dependerá de cada caso.(AU)


Subject(s)
Animals , Pigmentation Disorders/veterinary , Vitiligo/diagnosis , Horses
2.
Arq. bras. med. vet. zootec. (Online) ; 72(2): 565-572, Mar./Apr. 2020. ilus, tab
Article in Portuguese | LILACS, VETINDEX | ID: biblio-1128406

ABSTRACT

A marcha é um andamento natural de algumas raças de equinos, o qual resulta de movimentos coordenados, e é o andamento característico dos cavalos Campeiros. O objetivo do presente trabalho foi determinar relações entre medidas lineares e angulares com o tipo de marcha dos cavalos da raça Campeiro. Foram avaliados 113 equinos adultos, sendo realizadas 12 medidas lineares e 11 angulares de cada animal. Para obtenção das medidas lineares, utilizou-se hipômetro e fita métrica, e, para as medidas angulares, artrogoniômetro e podogoniômetro. Para avaliar e classificar a marcha, os animais foram montados e filmados por vista lateral. Dos 113 animais, 36 (32%) apresentaram marcha incompleta, 74 (65%) marcha completa, e três (3%) a guinilha. Dos equinos com marcha completa, 20 (27%) apresentaram marcha batida, 14 (19%) marcha de centro e 40 (54%) marcha picada. Apenas a medida linear, altura da garupa, apresentou diferença entre os tipos de andamentos (P<0,011). Pode-se concluir que as medidas lineares e angulares dos equinos Campeiros apresentam valores similares entre as variações da marcha, demonstrando equivalente morfologia independentemente da categoria da marcha.(AU)


The march is a natural gait of some breeds of horses, which results from coordinated movements, and is the characteristic gait of Campeiro horses. The objective of this study was to determine relationships between linear and angular measures with the type of march of the Campeiro racehorses. A total of 113 adult horses were evaluated and 12 linear and 11 angular measurements of each animal were performed. To obtain the linear measurements, we used a hypometer and a tape measure and for the angular measurements, an arthrogoniometer and podogoniometer. To evaluate and classify the gait the animals were mounted and filmed by lateral view. Of the 113 animals, 36 (32%) had an incomplete gait, 74 (65%) had a complete gait and three (3%) had a guinilha gait. Of the horses with complete gait, 20 (27%) presented batida quick march, 14 (19%) a central march and 40 (54%) a split march. Only the linear measure, the height of the rump, presented difference between the types of movements (P< 0.011). It can be concluded that the linear and angular measurements of the Campeiro equines present similar values between the march variations, demonstrating morphological equivalent regardless of the march category.(AU)


Subject(s)
Animals , Body Weights and Measures/veterinary , Gait , Horses/anatomy & histology
3.
Braz. j. med. biol. res ; 45(1): 72-77, Jan. 2012. tab
Article in English | LILACS | ID: lil-610549

ABSTRACT

The reduction of hepatic microsomal transfer protein (MTP) activity results in fatty liver, worsening hepatic steatosis and fibrosis in chronic hepatitis C (CHC). The G allele of the MTP gene promoter, -493G/T, has been associated with lower transcriptional activity than the T allele. We investigated this association with metabolic and histological variables in patients with CHC. A total of 174 untreated patients with CHC were genotyped for MTP -493G/T by direct sequencing using PCR. All patients were negative for markers of Wilson’s disease, hemochromatosis and autoimmune diseases and had current and past daily alcohol intake lower than 100 g/week. The sample distribution was in Hardy-Weinberg equilibrium. Among subjects with genotype 1, 56.8 percent of the patients with fibrosis grade 3+4 presented at least one G allele versus 34.3 percent of the patients with fibrosis grade 1+2 (OR = 1.8; 95 percentCI = 1.3-2.3). Logistic regression analysis with steatosis as the dependent variable identified genotypes GG+GT as independent protective factors against steatosis (OR = 0.4, 95 percentCI = 0.2-0.8; P = 0.01). The results suggest that the presence of the G allele of MTP -493G/T associated with lower hepatic MTP expression protects against steatosis in our CHC patients.


Subject(s)
Adult , Female , Humans , Carrier Proteins/genetics , Fatty Liver/genetics , Hepatitis C, Chronic/genetics , Polymorphism, Genetic/genetics , Disease Progression , Fatty Liver/metabolism , Fatty Liver/pathology , Genetic Predisposition to Disease , Genotype , Hepatitis C, Chronic/metabolism , Hepatitis C, Chronic/pathology , Polymerase Chain Reaction
4.
Braz. j. med. biol. res ; 39(1): 31-41, Jan. 2006. tab, graf
Article in English | LILACS | ID: lil-419147

ABSTRACT

Low bone remodeling and relatively low serum parathyroid hormone (PTH) levels characterize adynamic bone disease (ABD). The impact of renal transplantation (RT) on the course of ABD is unknown. We studied prospectively 13 patients with biopsy-proven ABD after RT. Bone histomorphometry and bone mineral density (BMD) measurements were performed in the 1st and 12th months after RT. Serum PTH, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and osteocalcin were measured regularly throughout the study. Serum PTH levels were slightly elevated at transplantation, normalized at the end of the third month and remained stable thereafter. Bone biopsies performed in the first month after RT revealed low bone turnover in all patients, with positive bone aluminum staining in 5. In the 12th month, second biopsies were performed on 12 patients. Bone histomorphometric dynamic parameters improved in 9 and were completely normalized in 6, whereas no bone mineralization was detected in 3 of these 12 patients. At 12 months post-RT, no bone aluminum was detected in any patient. We also found a decrease in lumbar BMD and an increase in femoral BMD. Patients suffering from ABD, even those with a reduction in PTH levels, may present partial or complete recovery of bone turnover after successful renal transplantation. However, it is not possible to positively identify the mechanisms responsible for the improvement. Identifying these mechanisms should lead to a better understanding of the physiopathology of ABD and to the development of more effective treatments.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Bone Density , Bone Diseases, Metabolic/etiology , Kidney Transplantation/adverse effects , Parathyroid Hormone/blood , Vitamin D/analogs & derivatives , Absorptiometry, Photon , Biopsy , Biomarkers/blood , Bone Diseases, Metabolic/blood , Bone Diseases, Metabolic/physiopathology , Calcitriol/blood , Osteocalcin/blood , Prospective Studies , Vitamin D/blood
5.
Braz. j. med. biol. res ; 38(1): 41-49, Jan. 2005. ilus, tab
Article in English | LILACS | ID: lil-405533

ABSTRACT

Brazil is a country of continental dimension with a population of different ethnic backgrounds. Thus, a wide variation in the frequencies of hepatitis C virus (HCV) genotypes is expected to occur. To address this point, 1,688 sequential samples from chronic HCV patients were analyzed. HCV-RNA was amplified by the RT-PCR from blood samples collected from 1995 to 2000 at different laboratories located in different cities from all Brazilian States. Samples were collected in tubes containing a gel separator, centrifuged in the site of collection and sent by express mail in a refrigerated container to Laboratório Bioquímico Jardim Paulista, São Paulo, SP, Brazil. HCV- RNA was extracted from serum and submitted to RT and nested PCR using standard procedures. Nested PCR products were submitted to cycle sequencing reactions without prior purification. Sequences were analyzed for genotype determination and the following frequencies were found: 64.9 percent (1,095) for genotype 1, 4.6 percent (78) for genotype 2, 30.2 percent (510) for genotype 3, 0.2 percent (3) for genotype 4, and 0.1 percent (2) for genotype 5. The frequencies of HCV genotypes were statistically different among Brazilian regions (P = 0.00017). In all regions, genotype 1 was the most frequent (51.7 to 74.1 percent), reaching the highest value in the North; genotype 2 was more prevalent in the Center-West region (11.4 percent), especially in Mato Grosso State (25.8 percent), while genotype 3 was more common in the South (43.2 percent). Genotypes 4 and 5 were rarely found and only in the Southeast, in São Paulo State. The present data indicate the need for careful epidemiological surveys throughout Brazil since knowing the frequency and distribution of the genotypes would provide key information for understanding the spread of HCV.


Subject(s)
Humans , Hepacivirus/genetics , Hepatitis C, Chronic/virology , RNA, Viral/genetics , /genetics , Base Sequence , Brazil/epidemiology , Genotype , Hepatitis C, Chronic/epidemiology , Molecular Sequence Data , Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Viral Envelope Proteins/genetics
6.
Genet. mol. res. (Online) ; 4(4): 803-811, 2005. tab, graf
Article in English | LILACS | ID: lil-444841

ABSTRACT

Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is characterized by the reciprocal translocation t(9;22)(q34;q11), which results in the BCR-ABL fusion gene on chromosome 22q-, also known as the Philadelphia chromosome. This chimeric gene codes for a cytoplasmic protein with constitutive tyrosine-kinase activity, responsible for cellular transformation and leukemogenesis in CML. The aim of this observational cohort study was to discriminate and quantify BCR-ABL transcripts in the peripheral blood of patients with CML who were treated with imatinib mesylate (Glivec, Novartis). Twenty-two patients were followed for six months during treatment. Quantitative real time polymerase chain reaction was performed before treatment and after 3 and 6 months from treatment initiation. As compared with the third month, there was a significant decrease in BCR-ABL expression in the sixth month of treatment (P = 0.0002). At the sixth month, there was a significant difference in the levels of the two major transcripts of BCR-ABL, B2A2 and B3A2 (P = 0.0347), indicating that B2A2 may be more sensitive to imatinib. The results of our study indicate that imatinib is able to modify the natural history of CML, and raise the hypothesis that patients who express the B2A2 transcript may have a better prognosis.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Antineoplastic Agents/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Fusion Proteins, bcr-abl/genetics , Transcription, Genetic/genetics , Analysis of Variance , Cohort Studies , Time Factors , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Fusion Proteins, bcr-abl/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Polymerase Chain Reaction/methods , Treatment Outcome , Transcription, Genetic/drug effects
7.
West Indian med. j ; 53(6): 387-391, Dec. 2004.
Article in English | LILACS | ID: lil-410085

ABSTRACT

Diabetes mellitus is a major cause of morbidity in Trinidad and Tobago. Screening programmes are not incorporated in the health sector and the population at risk remains unaware of the benefits of screening. We investigated the risk of developing Type 2 diabetes mellitus in office workers with one risk factor. Participants were randomly selected from the urban corporate sector in Port of Spain. Fasting capillary blood glucose and the American Diabetes Association (ADA) questionnaire for major diabetes risk factors were used to assess risk. Student pharmacists approached 482 persons, of whom 317 consented to participate (66 response rate). There were 101 (32) men and 216 (68) women, 37 (39) were of African ancestry and 28 each were of East Indian and mixed ancestry. Family history was positive in 54. Thirty per cent (95) of the volunteers were at risk of developing Type 2 diabetes mellitus (41 men; 54 women). Based on the ADA questionnaire, 82 (78) of volunteers were at high risk for developing Type 2 diabetes mellitus. The ADA risk test and Impaired Fasting Glucose were both positive in 13 (14) volunteers. In subjects at risk, Body Mass Index (BMI) was > 25 kg/m2 in 74 (78) and the waist/hip ratio was 0.85. Approximately 30 of office staff was at risk of developing diabetes mellitus. The ADA questionnaire is a useful non-invasive measure which pharmacists can use to assess risk for Type 2 diabetes mellitus. The glucometer can be used for risk assessment providing that it is associated with a quality assurance programme and that diagnosis is confirmed with laboratory testing


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Diabetes Mellitus, Type 2 , Risk Assessment/methods , Diabetes Mellitus, Type 2 , Body Constitution , Risk Factors , Blood Glucose/analysis , Glucose Intolerance , Surveys and Questionnaires , Glucose Tolerance Test , Trinidad and Tobago/epidemiology , Body Mass Index
8.
Braz. j. med. biol. res ; 36(3): 323-329, Mar. 2003. tab
Article in English | LILACS | ID: lil-329467

ABSTRACT

Patients with sickle-cell anemia submitted to frequent blood transfusions are at risk of contamination with hepatitis C virus (HCV). Determination of HCV RNA and genotype characterization are parameters that are relevant for the treatment of the viral infection. The objective of the present study was to determine the frequency of HCV infection and the positivity for HCV RNA and to identify the HCV genotype in patients with sickle-cell anemia with a history of blood transfusion who had been treated at the Hospital of the HEMOPE Foundation. Sera from 291 patients were tested for anti-HCV antibodies by ELISA 3.0 and RIBA 3.0 Chiron and for the presence of HCV RNA by RT-PCR. HCV genotyping was performed in 19 serum samples. Forty-one of 291 patients (14.1 percent) were anti-HCV positive by ELISA and RIBA. Both univariate and multivariate analysis showed a greater risk of anti-HCV positivity in those who had started a transfusion regime before 1992 and received more than 10 units of blood. Thirty-four of the anti-HCV-positive patients (34/41, 82.9 percent) were also HCV RNA positive. Univariate analysis, used to compare HCV RNA-negative and -positive patients, did not indicate a higher risk of HCV RNA positivity for any of the variables evaluated. The genotypes identified were 1b (63 percent), 1a (21 percent) and 3a (16 percent). A high prevalence of HCV infection was observed in our patients with sickle-cell anemia (14.1 percent) compared to the population in general (3 percent). In the literature, the frequency of HCV infection in sickle-cell anemia ranges from 2 to 30 percent. The serological screening for anti-HCV at blood banks after 1992 has contributed to a better control of the dissemination of HCV infection. Because of the predominance of genotype 1, these patients belong to a group requiring special treatment, with a probable indication of new therapeutic options against HCV


Subject(s)
Humans , Female , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Anemia, Sickle Cell , Blood Transfusion , Hepacivirus , Hepatitis C , Aged, 80 and over , Brazil , Enzyme-Linked Immunosorbent Assay , Genotype , Hepatitis C , Hepatitis C Antibodies , Immunoblotting , Prevalence , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , RNA, Viral
9.
West Indian med. j ; 52(1): 31-33, Mar. 2003.
Article in English | LILACS | ID: lil-410837

ABSTRACT

Extended-spectrum beta-lactamase (ESBL) mediated resistance to third generation cephalosporins, amongst the family Enterobacteriaceae, is emerging worldwide. This is the Caribbean's first survey on ESBL production, and was conducted during two six-month periods in 1998 and 2001, in a tertiary health institution in Trinidad and Tobago. Consecutive ampicillin resistant isolates of the family Enterobacteriaceae from in-patients were screened for resistance to third generation cephalosporins, and for ESBL production. The proportion of isolates found to be ESBL producers was similar in both samples (40 of 560 and 23 of 361). Overall, ESBL production was more frequent in enterobacter, citrobacter and proteus (and related organisms) than in Klebsiella and Escherichia (11.2 and 4.6, respectively, p < 0.001). In the 1998 sample, this proportion (9.8 versus 5.8) was significant (p < 0.05), but the difference was more marked in the 2001 sample (13.6 versus 2.9, p < 0.001). Continued distribution of these resistant bacterial strains is of concern. In the Caribbean region, more laboratory surveillance and increased infection control vigilance are recommended, with focus on specific genera in the family


Subject(s)
Humans , beta-Lactam Resistance/physiology , beta-Lactamases/metabolism , Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Trinidad and Tobago/epidemiology
10.
West Indian med. j ; 48(1): 23-25, Mar. 1999.
Article in English | LILACS | ID: lil-473124

ABSTRACT

Cerebral ischaemia was induced in anaesthetized rats by occlusion of the ipsilateral common carotid and middle cerebral arteries. The response to ischaemia was assessed by the reduction of the amplitude of recorded somatosensory evoked potentials (SSEPs), and the rate of recovery of the SSEPs during reperfusion. Caffeine and pentoxifylline when applied at 70 mM to the cortex for 60 min prior to induction of ischaemia significantly reduced the ischaemia induced attenuation of the SSEPs and hastened recovery to control levels. In contrast, application of normal saline or of the drugs for 15 min did not reduce the effect of ischaemia on the SSEPs. These results suggest that caffeine and pentoxifylline have potential roles in the management of patients with cerebral ischaemia.


Subject(s)
Male , Rats , Neuroprotective Agents/therapeutic use , Caffeine/therapeutic use , Central Nervous System Stimulants/therapeutic use , Brain Ischemia/prevention & control , Pentoxifylline/therapeutic use , Vasodilator Agents/therapeutic use , Evoked Potentials, Somatosensory , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/physiopathology , Time Factors , Brain Ischemia/physiopathology , Disease Models, Animal , Premedication , Rats, Sprague-Dawley , Reperfusion
11.
Rev. bras. genét ; 15(2): 449-57, June 1992. ilus
Article in English | LILACS | ID: lil-109134

ABSTRACT

Os autores relatam um caso de leucemia linfoblástica aguda (ALL) que no exame citogenético de células da medula óssea apresentou manomalias cromossômicas já descritas nesta condiçäo del(6)(q23); t(9;22)(q34;q11), ao lado das alteraçöes cromossômicas del(4)(p14) + 4ace e t(4;15)(p14;pter) ainda näo relatadas em ALL. Discutem a hipótese destas alteraçöes influenciarem na origem da malignidade, na pobre resposta ao tratamento e mau prognóstico observado no paciente pela possível ativaçäo de oncogenes em consequência das anomalias observadas


Subject(s)
Chromosome Aberrations/therapy , Cytogenetics , Leukemia, Lymphoid , Prognosis , Chromosome Aberrations/prevention & control , Oncogenes
SELECTION OF CITATIONS
SEARCH DETAIL